BlackRock Amends Zoetis Stake, Signals Continued Institutional Interest

TL;DR

**BlackRock still a major player in Zoetis, good sign for stability.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating a change in its ownership stake in Zoetis Inc. as of December 31, 2023. This filing, Amendment No. 9, shows BlackRock continues to be a significant institutional investor in Zoetis, holding Class A Common Stock. This matters to investors because large institutional holdings like BlackRock's can signal confidence in a company's long-term prospects and influence stock stability.

Why It Matters

This filing confirms BlackRock's ongoing substantial investment in Zoetis, which can be a positive signal for other investors and contribute to the stock's perceived stability.

Risk Assessment

Risk Level: low — This filing is routine for large institutional investors and does not indicate any immediate negative risks for Zoetis Inc. shareholders.

Analyst Insight

An investor should note BlackRock's continued presence as a major shareholder, which often indicates institutional confidence, but should also conduct their own due diligence on Zoetis Inc.'s fundamentals.

Key Players & Entities

• BlackRock Inc. (company) — the reporting person and institutional investor
• Zoetis Inc. (company) — the subject company in which BlackRock holds shares
• Delaware (company) — state of incorporation for BlackRock, Inc.
• December 31, 2023 (date) — the date of the event which required the filing
• January 26, 2024 (date) — the date the SC 13G/A was filed
• 98978V103 (other) — CUSIP Number for Zoetis Inc. Class A Common Stock

Forward-Looking Statements

• BlackRock will maintain a significant ownership stake in Zoetis Inc. throughout 2024. (BlackRock Inc.) — high confidence, target: December 31, 2024

FAQ

From the Filing

0001086364-24-004309.txt : 20240126 0001086364-24-004309.hdr.sgml : 20240126 20240126114941 ACCESSION NUMBER: 0001086364-24-004309 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87352 FILM NUMBER: 24565818 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us98978v1035_012624.txt us98978v1035_012624.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) ZOETIS INC -------------------------------------------------------- (Name of Issuer) Class A Common Stock -------------------------------------------------------- (Title of Class of Securities) 98978V103 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 98978V103 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 32997931 (6) Shared voting power 0 (7) Sole dispositive power 36492748 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 36492748 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 7.9% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- ZOETIS INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 10 SYLVAN WAY PARSIPPANY NJ 07054 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Y